ZW10385A1 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity - Google Patents

Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity

Info

Publication number
ZW10385A1
ZW10385A1 ZW103/85A ZW10385A ZW10385A1 ZW 10385 A1 ZW10385 A1 ZW 10385A1 ZW 103/85 A ZW103/85 A ZW 103/85A ZW 10385 A ZW10385 A ZW 10385A ZW 10385 A1 ZW10385 A1 ZW 10385A1
Authority
ZW
Zimbabwe
Prior art keywords
thiadiazoles
histamine
diamino
substituted
receptor antagonist
Prior art date
Application number
ZW103/85A
Other languages
English (en)
Inventor
Antonio Algieri Aldo
Ray Crenshaw Ronnie
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZW10385A1 publication Critical patent/ZW10385A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZW103/85A 1984-06-22 1985-06-21 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity ZW10385A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (1)

Publication Number Publication Date
ZW10385A1 true ZW10385A1 (en) 1986-02-05

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW103/85A ZW10385A1 (en) 1984-06-22 1985-06-21 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity

Country Status (33)

Country Link
US (1) US4644006A (xx)
JP (2) JPS6118775A (xx)
KR (1) KR900004321B1 (xx)
AR (1) AR240935A1 (xx)
AT (1) AT390790B (xx)
AU (2) AU580605B2 (xx)
BE (1) BE902724A (xx)
CA (2) CA1267412A (xx)
CH (1) CH665210A5 (xx)
CS (1) CS257276B2 (xx)
DD (1) DD240889A5 (xx)
DE (1) DE3522101A1 (xx)
DK (1) DK282885A (xx)
ES (2) ES8702902A1 (xx)
FI (1) FI852405L (xx)
FR (1) FR2566406B1 (xx)
GB (2) GB2161157B (xx)
GR (1) GR851514B (xx)
HU (1) HU193992B (xx)
IE (2) IE58261B1 (xx)
IL (1) IL75567A0 (xx)
IT (1) IT1190372B (xx)
LU (1) LU85969A1 (xx)
NL (1) NL8501766A (xx)
NO (1) NO161856C (xx)
NZ (1) NZ212403A (xx)
OA (1) OA08039A (xx)
PT (1) PT80684B (xx)
SE (1) SE464305B (xx)
SU (1) SU1537136A3 (xx)
YU (2) YU45725B (xx)
ZA (1) ZA854710B (xx)
ZW (1) ZW10385A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
EP0045155B1 (en) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
NL8301063A (nl) * 1982-03-29 1983-10-17 Bristol Myers Co Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden.
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
AU2977589A (en) 1989-06-01
KR900004321B1 (ko) 1990-06-22
DK282885A (da) 1985-12-23
NO161856B (no) 1989-06-26
FR2566406A1 (fr) 1985-12-27
NO852519L (no) 1985-12-23
ATA185885A (de) 1989-12-15
DK282885D0 (da) 1985-06-21
JPS6118775A (ja) 1986-01-27
IE58261B1 (en) 1993-08-25
CA1297875C (en) 1992-03-24
JPS61186369A (ja) 1986-08-20
AU614331B2 (en) 1991-08-29
ES8702902A1 (es) 1987-01-16
BE902724A (fr) 1985-12-23
ES544409A0 (es) 1987-01-16
IT1190372B (it) 1988-02-16
YU105185A (en) 1987-12-31
FI852405A0 (fi) 1985-06-17
HUT42087A (en) 1987-06-29
KR860000275A (ko) 1986-01-27
GB2161157A (en) 1986-01-08
SE8503110L (sv) 1985-12-23
SE8503110D0 (sv) 1985-06-20
AT390790B (de) 1990-06-25
CS424785A2 (en) 1987-09-17
DD240889A5 (de) 1986-11-19
CA1267412A (en) 1990-04-03
SU1537136A3 (ru) 1990-01-15
YU45725B (sh) 1992-07-20
PT80684B (en) 1987-05-08
ES551506A0 (es) 1987-01-16
GB8716149D0 (en) 1987-08-12
CH665210A5 (de) 1988-04-29
AU4392085A (en) 1986-01-02
ES8702881A1 (es) 1987-01-16
PT80684A (en) 1985-07-01
AR240935A1 (es) 1991-03-27
GB2161157B (en) 1988-08-10
IE851557L (en) 1985-12-22
YU45822B (sh) 1992-07-20
HU193992B (en) 1987-12-28
GB8515749D0 (en) 1985-07-24
CS257276B2 (en) 1988-04-15
GR851514B (xx) 1985-11-25
IL75567A0 (en) 1985-10-31
FR2566406B1 (fr) 1988-01-29
AR240935A2 (es) 1991-03-27
YU102587A (en) 1988-02-29
AU580605B2 (en) 1989-01-19
DE3522101A1 (de) 1986-01-02
IT8521217A0 (it) 1985-06-20
OA08039A (fr) 1987-01-31
SE464305B (sv) 1991-04-08
NZ212403A (en) 1989-04-26
IE57937B1 (en) 1993-05-19
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
FI852405L (fi) 1985-12-23
US4644006A (en) 1987-02-17
GB2192884A (en) 1988-01-27
ZA854710B (en) 1986-02-26
GB2192884B (en) 1988-08-10
LU85969A1 (fr) 1986-01-24

Similar Documents

Publication Publication Date Title
IL79215A0 (en) Substituted 4,5-dihydro-1,3,4-thiadiazoles
GB8515979D0 (en) Toolholder
ZA832154B (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity
ZW10385A1 (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity
ZA849273B (en) Pyridone derivatives with histamine h2-receptor antagonist activity
GB8414132D0 (en) Lock mechanisms
GB8510308D0 (en) Lock
GB2159866B (en) Lock
GR80439B (en) 2,5 disubstituted-4(3h)-pyrimidones having histamine h2-receptor antagonist activity
GB2161539B (en) Lock mechanisms
El-Badry Pyridine and reduced pyridine analogs as histamine H2-receptor antagonists
AU5067985A (en) 1,2,4-thiadiazole derivatives
SU1246568A1 (ru) 2`,2`,5,7-тетраметил-6-оксоспиро-(1,3-диазаадамантан- 2,4′ -тетрагидротиопиран), обладающий противостафилококковой активностью
IE842695L (en) Histamine h2 - antagonists
EP0154906A3 (en) 3-cyclopropylmethyl-1,3,5-triazine-2,4-dione
IE841721L (en) Pyrimidin-2-thiones and -2-ones, histamine h2-antagonists
SU1221878A1 (ru) I′ -БЕНЗИЛ-5,7-ДИМЕТИЛ-6-ОКСОСПИРО-(1,3-ДИАЗААДАМАНТАН- 2,4′ -ПИПЕРИДИН), ОБЛАДАЮЩИЙ α -АДРЕНОБЛОКИРУЮЩЕЙ АКТИВНОСТЬЮ
IE841246L (en) Pyridines, microbicides
GB2167750B (en) Isothiuronium salts
IE820466L (en) 2-amino-5-(sulphamidophenyl)-1,3,4-thiadiazoles, anti-viral¹agents
GB8432134D0 (en) Double toolholder
GB8409951D0 (en) Rake
AU91718S (en) Rake
GB8421780D0 (en) Blocking stylette
IE841153L (en) Thiadiazoles